Skip to main content
. 2021 Jan;10(1):154–163. doi: 10.21037/tau-20-994

Table 1. Cumulative incidences of death from prostate cancer and other causes with patient and tumor characteristics.

Characteristic No of patients Prostate cancer Other Causes
No of deaths 5 year (%) (95% CI) 10 year (%) (95% CI) P value No of deaths 5 year (%) (95% CI) 10 year (%) (95% CI) P value
All patients 30,538 358 0.67 (0.56–0.78) 2.75 (2.37–3.06) 2,727 6.58 (6.05–6.70) 19.33 (17.76–20.52)
Race 0.23 <0.001
   Other 1,611 13 0.25 (0–0.55) 2.28 (0.73–3.75) 102 4.30 (3.02–5.38) 16.14 (11.28–18.38)
   White 23,686 274 0.65 (0.52–0.77) 2.77 (2.34–3.12) 2,075 6.29 (5.73–6.45) 19.25 (17.48–20.30)
   Black 5,241 71 0.92 (0.60–1.22) 2.82 (1.97–3.58) 550 8.67 (7.44–9.16) 22.35 (18.47–22.86)
Marital status <0.001 <0.001
   Married 22,037 222 0.55 (0.43–0.66) 2.47 (2.06–2.83) 1,742 5.60 (5.10–5.81) 17.62 (15.85–18.32)
   Unmarried 8,501 136 1.0 (0.74–1.24) 3.46 (2.69–4.10) 985 9.19 (8.08–9.48) 24.82 (21.56–26.40)
cT stage 0.27 0.086
   T1 28,663 333 0.66 (0.55–0.77) 2.7 (2.3–3.01) 2,552 6.56 (6.02–6.68) 19.21 (17.60–20.35)
   T2a 1,875 25 0.91 (0.38–1.42) 3.49 (1.86–5.0) 175 7.0 (5.37–8.08) 23.38 (17.30–24.25)
ISUP grade <0.001 <0.001
   1 25,376 240 0.53 (0.42–0.63) 2.14 (1.79–2.45) 2,047 5.86 (5.35–6.0) 18.0 (16.27–18.77)
   2 5,162 118 1.39 (1.0–1.76) 5.77 (4.40–6.79) 680 10.30 (8.82–10.70) 27.60 (23.46–29.52)

CI, confidence interval; cT stage, clinical T stage; ISUP, International Society of Urological Pathology.